GD vs KYMR · P/E 22, rev $52.55B vs rev $99.4M
General Dynamics Corporation (GD) versus Kymera Therapeutics Inc (KYMR) — a side-by-side from cached financials, not a winner call.
General Dynamics Corporation (GD) is a aerospace & defense company listed on US.
Kymera Therapeutics Inc (KYMR) is a biotechnology company listed on NASDAQ.
Latest reported GD revenue for 2025-12-31 was $52.55B. Net income was $4.21B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. GD currently screens at market cap $93.69B and trailing P/E 21.8.
Latest reported KYMR revenue for 2026-06-30 was $99.4M. Net income was -$130.4M. KYMR currently screens at market cap $7.39B.
GD currently screens at market cap $93.69B and trailing P/E 21.8. KYMR currently screens at market cap $7.39B.
Not investment advice. Open the GD and KYMR stock pages for the full models.
Not investment advice.